BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33612479)

  • 1. Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
    Huang J; Zhang Q; Shen J; Chen X; Ma S
    Aging (Albany NY); 2021 Feb; 13(4):5946-5966. PubMed ID: 33612479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
    Gao X; Jiang A; Shen Y; Lu H; Chen R
    Medicine (Baltimore); 2021 Aug; 100(31):e26439. PubMed ID: 34397793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB.
    Wang L; Xiao X; Du H
    Mol Biotechnol; 2022 May; 64(5):526-534. PubMed ID: 34997902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
    Sun G; Ni K; Shen J; Liu D; Wang H
    Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma.
    Zhang J; Ma J; Li Y; An Y; Du W; Yang Q; Huang M; Cai X
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
    Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
    Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
    Tang X; Zhou H; Liu Y
    Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
    Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
    J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
    Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
    BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AURKB promotes gastric cancer progression via activation of
    Nie M; Wang Y; Yu Z; Li X; Deng Y; Wang Y; Yang D; Li Q; Zeng X; Ju J; Liu M; Zhao Q
    Aging (Albany NY); 2020 Jan; 12(2):1304-1321. PubMed ID: 31982864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
    Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer.
    Hu T; Wang X; Xia Y; Wu L; Ma Y; Zhou R; Zhao Y
    Chin Med J (Engl); 2022 Sep; 135(18):2218-2231. PubMed ID: 36113844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
    Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.